Pharmaceutical News and Articles

ACG: Hormone Therapy Tied to Higher Risk for New Irritable Bowel Syndrome

Hormone replacement therapy (HRT) is associated with an increased risk for developing irritable bowel syndrome (IBS) in postmenopausal women, according to a stu

Doctors Report First U.S. Cases of Sexually Transmitted Ringworm Rash

Doctors in New York City are describing the first known U.S. cases of sexually transmitted ringworm, which can cause a nasty rash that can take months to bring

When This Black Cat Crossed His Path, It Was a Lucky Day for Medicine

he developed no symptoms from his exposure to the mouse. Cats, in general, evolved to eat rodents, and are not sickened by the viruses carried by rodents, Ledni

Most Patients Can Keep Using GLP-1 Weight Loss Meds Before Surgeries

should wait till these symptoms ease before undergoing surgery. Some patients, such as those with Parkinson s disease, already have slowed gastric emptying, so

Election Fears Are Keeping Americans Awake at Night, Survey Shows

say the election has negatively impacted their sleep, according to a survey by the National Sleep Foundation.These folks are sleeping less on the weekend and ha

Bird Flu Infection Confirmed in a Pig for First Time in U.S.

Amid an ongoing outbreak of bird flu in poultry and dairy cows in the United States, a case of H5N1 has now been confirmed for the first time in a pig. The U.S.

Study Suggests Earlier Is Better for Heart Valve Replacement Procedures

In a finding that challenges conventional thinking on when people with failing heart valves but no symptoms should get surgery, a new study suggests these patie

PTC Therapeutics Announces FDA Acceptance of Translarna NDA Resubmission

Monthly News Roundup - October 2024

FDA Approves AbbVie s Vyalev to Treat Advanced Parkinson Disease In October, the US Food and Drug Administration (FDA) approved Vyalev (foscarbidopa and foslevo

Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer

Tokyo and Basking Ridge, NJ (October 30, 2024) The first patients have been dosed in three global, randomized phase 3 trials evaluating the efficacy and safety